跳转至内容
Merck

GF31001960

foil, 25x25mm, thickness 2.0mm, 100%

别名:

登录查看公司和协议定价


About This Item

经验公式(希尔记法):
Bi
CAS号:
分子量:
208.98
MDL號碼:
分類程式碼代碼:
12141706
PubChem物質ID:
NACRES:
NA.23

蒸汽壓力

<0.1 mmHg ( 20 °C)

化驗

100%

形狀

foil

製造商/商標名

Goodfellow 310-019-60

電阻係數

129 μΩ-cm, 20°C

尺寸 × 厚度

25x25 mm × 2.0 mm

bp

1560 °C (lit.)

mp

271 °C (lit.)

密度

9.8 g/mL at 25 °C (lit.)

SMILES 字串

[Bi]

InChI

1S/Bi

InChI 密鑰

JCXGWMGPZLAOME-UHFFFAOYSA-N

正在寻找类似产品? 访问 产品对比指南

一般說明

For updated SDS information please visit www.goodfellow.com.

法律資訊

Product of Goodfellow

从最新的版本中选择一种:

分析证书(COA)

Lot/Batch Number

抱歉,我们目前尚未线上提供该产品的COA。

如需帮助,请联系 客户支持

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Hong Lu et al.
European journal of gastroenterology & hepatology, 25(10), 1134-1140 (2013-06-20)
Antimicrobial resistance has continued to undermine many popular anti-Helicobacter pylori therapies. Antibiotic resistance to commonly used anti-H. pylori drugs in China has increased markedly, making China an ideal site to identify regimens that remain effective despite widespread antimicrobial resistance. Bismuth
Jorge A R Salvador et al.
Molecules (Basel, Switzerland), 16(4), 2884-2913 (2011-04-06)
Steroid and terpene chemistry still have a great impact on medicinal chemistry. Therefore, the development of new reactions or "greener" processes in this field is a contemporaneous issue. In this review, the use of bismuth(III) salts, as "ecofriendly" reagents/catalysts, on
Jorge A R Salvador et al.
Future medicinal chemistry, 4(11), 1495-1523 (2012-08-04)
In recent years, the chemical potential of bismuth and bismuth compounds has been actively exploited. Bismuth salts are known for their low toxicity, making them potential valuable reagents for large-scale synthesis, which becomes more obvious when dealing with products such
Syntheses of biodegradable and biocompatible polymers by means of bismuth catalysts.
Hans R Kricheldorf
Chemical reviews, 109(11), 5579-5594 (2009-09-26)
P Moayyedi et al.
Alimentary pharmacology & therapeutics, 17(10), 1215-1227 (2003-05-21)
Evidence for the effectiveness of antacids, histamine-2 receptor antagonists, bismuth salts, sucralfate and prokinetic therapy in non-ulcer dyspepsia is conflicting. To conduct a systematic review evaluating these therapies in non-ulcer dyspepsia. Electronic searches were performed using the Cochrane Controlled Trials

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门